Traenka Christopher, Disanto Giulio, Seiffge David J, Gensicke Henrik, Hert Lisa, Grond-Ginsbach Caspar, Peters Nils, Regeniter Axel, Kloss Manja, De Marchis Gian Marco, Bonati Leo H, Lyrer Philippe A, Kuhle Jens, Engelter Stefan T
Department of Neurology and Stroke Center, University Hospital of Basel, Basel, Switzerland.
Cerebrovasc Dis. 2015;40(5-6):222-7. doi: 10.1159/000440774. Epub 2015 Sep 30.
Serum neurofilament light chain (sNfL) levels represent a promising marker of neuroaxonal injury. They are elevated in several neurological conditions, but their importance in cerebrovascular diseases remains unclear. In a proof of concept study, we compared sNfL levels with clinical characteristics and outcome in patients with cervical artery dissection (CeAD).
A total of 49 non-traumatic CeAD patients were included. sNfL levels were measured by high-sensitivity electrochemiluminescence immunoassay. Levels were compared with regard to (i) type of presenting symptoms (local symptoms only (n = 8), transient ischemic attack (TIA; n = 10) or ischemic stroke (n = 31)), (ii) stroke severity quantified by National Institute of Health Stroke Scale (NIHSS), (iii) time interval between onset of symptoms and blood sampling and (iv) 3-month outcome as measured by the modified Rankin Scale score. Analyses were performed using univariate and multivariate linear and ordinal regression models.
CeAD patients presenting with stroke had significantly higher sNfL levels (median 108.9 pg/ml, interquartile range (37.8-427.7)) than patients with TIA (16.4 pg/ml (8.7-36.3), p = 0.002) or local symptoms (23.4 pg/ml (17.8-30.8), p = 0.0007). Among stroke patients, sNfL levels were positively associated with both NIHSS (p = 0.0002) and time between stroke onset and serum sampling (p = 1.9 × 10-6). Higher sNfL levels were associated with unfavorable outcome at 3 months (OR 4.67, 95% CI 1.69-12.95, p = 0.003). However, this association lost significance after adjustment for NIHSS. The highest sNfL level was observed in a TIA patient who had ischemic stroke 1 day after serum sampling for sNfL measurement.
sNfL levels were increased in CeAD patients presenting with stroke, correlated with clinical severity and were influenced by the time point of blood sampling. The prognostic meaning of sNfL in CeAD deserves further testing.
血清神经丝轻链(sNfL)水平是神经轴突损伤的一个有前景的标志物。在几种神经系统疾病中其水平会升高,但其在脑血管疾病中的重要性仍不明确。在一项概念验证研究中,我们比较了颈内动脉夹层(CeAD)患者的sNfL水平与临床特征及预后。
共纳入49例非创伤性CeAD患者。采用高灵敏度电化学发光免疫分析法测量sNfL水平。就以下方面比较水平:(i)首发症状类型(仅局部症状(n = 8)、短暂性脑缺血发作(TIA;n = 10)或缺血性卒中(n = 31)),(ii)由美国国立卫生研究院卒中量表(NIHSS)量化的卒中严重程度,(iii)症状发作与采血之间的时间间隔,以及(iv)改良Rankin量表评分所测量的3个月预后。使用单变量和多变量线性及有序回归模型进行分析。
出现卒中的CeAD患者的sNfL水平(中位数108.9 pg/ml,四分位间距(37.8 - 427.7))显著高于TIA患者(16.4 pg/ml(8.7 - 36.3),p = 0.002)或有局部症状的患者(23.4 pg/ml(17.8 - 30.8),p = 0.0007)。在卒中患者中,sNfL水平与NIHSS(p = 0.0002)以及卒中发作与血清采样之间的时间均呈正相关(p = 1.9×10⁻⁶)。较高的sNfL水平与3个月时的不良预后相关(比值比4.67,95%置信区间1.69 - 12.95,p = 0.003)。然而,在对NIHSS进行调整后,这种关联失去了显著性。在一名TIA患者中观察到最高的sNfL水平,该患者在采集用于测量sNfL的血清样本1天后发生了缺血性卒中。
出现卒中的CeAD患者的sNfL水平升高,与临床严重程度相关,并受采血时间点的影响。sNfL在CeAD中的预后意义值得进一步检验。